Xiao-Jing Zhou1, Zhi-Ming Zhao2, Peng Liu1, Cong-Ying Zhao1, Yu-Jie Lin3, Ying Liu1, Min Wang4, Cai Tian1, Hai-Yan Li1, Chen-Xiao Hou1, Xiu-Min Li5, Zhi-Yu Zhao6, Ying-Jie Zhou7. 1. Seven Section of Department of Gynaecology, the Second Hospital of Hebei Medical University, Shijiazhuang, China. 2. Department of Reproductive Medicine, the Second Hospital of Hebei Medical University, Shijiazhuang, China. 3. Department of Ultrasound, the Ninth Hospital of Xingtai City (the Hospital of Julu County), Xingtai, China. 4. Department of Ultrasound, Tang County Hospital of Traditional Chinese Medicine, Tang County, China. 5. Department of Ultrasound, Dingzhou Traditional Chinese Medicine Hospital, Dingzhou, China. 6. Department of Gynecology, Zhengding Maternal and Child Health Hospital, Zhengding, China. 7. Seven Section of Department of Gynaecology, the Second Hospital of Hebei Medical University, Shijiazhuang, China. yingjiehero@163.com.
Abstract
BACKGROUND: Cystic adenomyosis is a particular type of adenomyosis, High intensity focused ultrasound (HIFU), as a non-invasive method, has also been used to treat adenomyosis. The purpose of this study was to investigate the efficacy, safety, and feasibility of HIFU for the treatment of cystic adenomyosis. METHODS: Diagnosis of cystic adenomyosis was obtained through trans-vaginal ultrasound and magnetic resonance imaging (MRI). Ultrasound-guided HIFU ablation was performed under conscious sedation. The patients were evaluated by the comparison of pre-HIFU and post-HIFU imaging, as well as the Uterine Fibroid Symptom and Quality of Life (UFS-QOL) questionnaire subscales, consisting of Symptom Severity Score (SSS) and Heath Related Quality of Life (HRQL). RESULTS: HIFU was effective in treating cystic adenomyosis. No complications were observed in the four patients who were successfully treated with HIFU. Compared to preoperative symptoms and patient satisfaction, symptoms at the first follow-up observed significant improvements, with no dysmenorrhea and high health-related quality of life. During the outpatient follow-up of one month, three months, and six months postoperation, the four patients were still without dysmenorrhea and were highly satisfied with the HIFU ablation. CONCLUSIONS: HIFU, as a non-invasive treatment, supplies a safe and effective possibility for the treatment of cystic adenomyosis.
BACKGROUND:Cystic adenomyosis is a particular type of adenomyosis, High intensity focused ultrasound (HIFU), as a non-invasive method, has also been used to treat adenomyosis. The purpose of this study was to investigate the efficacy, safety, and feasibility of HIFU for the treatment of cystic adenomyosis. METHODS: Diagnosis of cystic adenomyosis was obtained through trans-vaginal ultrasound and magnetic resonance imaging (MRI). Ultrasound-guided HIFU ablation was performed under conscious sedation. The patients were evaluated by the comparison of pre-HIFU and post-HIFU imaging, as well as the Uterine Fibroid Symptom and Quality of Life (UFS-QOL) questionnaire subscales, consisting of Symptom Severity Score (SSS) and Heath Related Quality of Life (HRQL). RESULTS:HIFU was effective in treating cystic adenomyosis. No complications were observed in the four patients who were successfully treated with HIFU. Compared to preoperative symptoms and patient satisfaction, symptoms at the first follow-up observed significant improvements, with no dysmenorrhea and high health-related quality of life. During the outpatient follow-up of one month, three months, and six months postoperation, the four patients were still without dysmenorrhea and were highly satisfied with the HIFU ablation. CONCLUSIONS:HIFU, as a non-invasive treatment, supplies a safe and effective possibility for the treatment of cystic adenomyosis.
Entities:
Keywords:
High intensity focused ultrasound (HIFU); Uterine Fibroid Symptom and Quality of Life questionnaire subscales (UFS-QOL questionnaire subscales); cystic adenomyosis; non-invasive; treatment